Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01558_DB01601_nanopub.RAK6aduuV8WH5S05i2NgDKVg2CYacKfIE6pZfg0vk-IMs#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01558_DB01601 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01558_DB01601 label "DDI between Bromazepam and Lopinavir - Lopinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of bromazepam by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of bromazepam if lopinavir is initiated, discontinued or dose changed. Dosage adjustments may be required. [drugbank_resource:DB01558_DB01601]" assertion.
- drugbank_resource:DB01558_DB01601 identifier "drugbank_resource:DB01558_DB01601" assertion.
- drugbank_resource:DB01558_DB01601 title "DDI between Bromazepam and Lopinavir - Lopinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of bromazepam by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of bromazepam if lopinavir is initiated, discontinued or dose changed. Dosage adjustments may be required." assertion.
- drugbank:DB01601 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01558_DB01601 assertion.
- drugbank:DB01558 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01558_DB01601 assertion.